Subscribe
Healthcare

FDA pulls emergency use authorization for hydroxychloroquine, the drug touted by Trump as COVID-19 remedy

By Cassidy Morrison
Published
Add Washington Examiner on Google
FDA pulls emergency use authorization for hydroxychloroquine, the drug touted by Trump as COVID-19 remedy

The Food and Drug Administration has rescinded authorizations for hydroxychloroquine and chloroquine, promoted by President Trump as coronavirus treatments, as evidence begins to show the drugs may be harmful.

“We now believe that the suggested dosing regimens for [ hydroxychloroquine and chloroquine] as detailed in the Fact Sheets are unlikely to produce an antiviral effect,” FDA Chief Scientist Denise Hinton said Monday.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 Department of Health and Human Services FDA Hydroxychloroquine Trump Administration